Related Experiment Video
Updated: Sep 20, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
[Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway]
Yi Zhang1, Li-guang Sun, Hai Shang
1Department of Gynecology, First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Objective:
To explore the expression of acidic fibroblast growth factor (aFGF) and its receptor FGFR1 in ovarian epithelial cancer and observe the effects of aFGF and TPK inhibitor Genistein on intracellular PKC and ERK activity in ovarian epithelial cancer cells line CAOV3.
Methods:
The expression levels of aFGF and FGFR1 were evaluated by RT-PCR and western blot in 40 cases of ovarian epithelial cancer. The activity of PKC and ERK in cells induced by different concentration of aFGF and Genistein were detected by incorporation of [gamma-(32)P]-ATP into exogenous substrate.
Results:
The expression levels of aFGFmRNA and FGFR1mRNA in the ovarian epithelial cancer were 0.981 +/- 0.130 and 1.047 +/- 0.148, respectively. Compared with normal ovary, ovarian tumor like condition and benign ovary tumors, the difference was significant (P < 0.05). The expression levels in stage III - IV were significantly higher than those in stage I - II (P < 0.05). There were overexpression of aFGF and FGFR1 in the ovarian epithelial cancer in western blot, too. The intracellular PKC and ERK activity increased with aFGF in a dose dependent manner, Genistein suppressed the intracellular PKC and ERK activity also in a dose dependent manner.
Conclusion:
aFGF may play an important role in carcinogenesis, development and invasion of ovarian epithelial cancer. Its receptor in human ovarian cancer cell line CAOV3 possessed TPK activity. These tyrosine-specific protein phosphorylation may initiate a cascade of biochemical events, which may increase the intracellular PKC and ERK activity. PKC and ERK locate downstream of TPK in CAOV3 cell line.
Insights
Acidic fibroblast growth factor (aFGF) and its receptor FGFR1 are overexpressed in ovarian epithelial cancer, potentially driving tumor progression. Inhibition of tyrosine-specific protein phosphorylation by Genistein suppressed intracellular PKC and ERK activity in CAOV3 cells.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Ovarian epithelial cancer is a significant health concern with complex molecular underpinnings.
- Acidic fibroblast growth factor (aFGF) and its receptor FGFR1 are implicated in various cancers.
- Understanding signaling pathways is crucial for developing targeted therapies.
Purpose:
- To investigate the expression of aFGF and FGFR1 in ovarian epithelial cancer.
- To examine the impact of aFGF and the tyrosine-specific protein kinase (TPK) inhibitor Genistein on intracellular protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) activity.
- To explore the role of these molecules in ovarian cancer cell line CAOV3.
Summary:
- RT-PCR and Western blot analysis revealed significant overexpression of aFGF and FGFR1 in ovarian epithelial cancer tissues, particularly in advanced stages (III-IV).
- aFGF stimulation dose-dependently increased intracellular PKC and ERK activity in CAOV3 cells.
- Genistein effectively suppressed PKC and ERK activity in a dose-dependent manner, indicating TPKs are upstream of these pathways in CAOV3 cells.
Impact:
- The findings suggest aFGF plays a critical role in the carcinogenesis, development, and invasion of ovarian epithelial cancer.
- The study highlights the potential of targeting the aFGF/FGFR1 pathway and downstream kinases (PKC, ERK) for therapeutic intervention.
- This research provides insights into the molecular mechanisms underlying ovarian cancer progression and identifies potential therapeutic targets.
Related Concept Videos
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply

